Search research articles
Contact Us
Filters
Showing results (1-10 of 73) with videos related to
Page
of 8
Sort By:
Plos One
|
February 20, 2025
Optimal two-stage group sequential designs based on Mann-Whitney-Wilcoxon test
Yeonhee Park
Annals of Translational Medicine
|
October 21, 2022
Challenges and opportunities in biomarker-driven trials: adaptive randomization
Yeonhee Park
Contemporary Clinical Trials Communications
|
October 3, 2022
Interval design to identify the optimal biological dose for immunotherapy
Yeonhee Park
Journal of Personalized Medicine
|
March 25, 2022
Personalized Risk-Based Screening Design for Comparative Two-Arm Group Sequential Clinical Trials
Yeonhee Park
Plos One
|
February 8, 2021
Optimal two-stage design of single arm Phase II clinical trials based on median event time test
Yeonhee Park
Statistics in Medicine
|
March 18, 2026
ESPLSM: An Efficient and Interpretable Mediation Analysis Framework Using Sparse Envelopes
Yeonhee Park, Zhihua Su
Contemporary Clinical Trials
|
April 11, 2022
A randomized group sequential enrichment design for immunotherapy and targeted therapy
Yeonhee Park, Suyu Liu
Journal of Biopharmaceutical Statistics
|
December 22, 2023
Data-driven monitoring for phase II clinical trial designs based on percentile event time test
Yeonhee Park, Zhanpeng Xu
Biometrics
|
April 7, 2020
Discussion on "Predictively consistent prior effective sample sizes," by Beat Neuenschwander, Sebastian Weber, Heinz Schmidli, and Anthony O'Hagan
Yeonhee Park, Ruitao Lin
Statistical Methods in Medical Research
|
July 17, 2025
Group sequential designs for survival outcomes with adaptive randomization
Yaxian Chen, Yeonhee Park
Page
of 8
Search research articles
Search
Showing results (1-10 of 73) with videos related to
Sort By:
Page
of 8
Plos One
|
February 20, 2025
Optimal two-stage group sequential designs based on Mann-Whitney-Wilcoxon test
Yeonhee Park
Annals of Translational Medicine
|
October 21, 2022
Challenges and opportunities in biomarker-driven trials: adaptive randomization
Yeonhee Park
Contemporary Clinical Trials Communications
|
October 3, 2022
Interval design to identify the optimal biological dose for immunotherapy
Yeonhee Park
Journal of Personalized Medicine
|
March 25, 2022
Personalized Risk-Based Screening Design for Comparative Two-Arm Group Sequential Clinical Trials
Yeonhee Park
Plos One
|
February 8, 2021
Optimal two-stage design of single arm Phase II clinical trials based on median event time test
Yeonhee Park
Statistics in Medicine
|
March 18, 2026
ESPLSM: An Efficient and Interpretable Mediation Analysis Framework Using Sparse Envelopes
Yeonhee Park, Zhihua Su
Contemporary Clinical Trials
|
April 11, 2022
A randomized group sequential enrichment design for immunotherapy and targeted therapy
Yeonhee Park, Suyu Liu
Journal of Biopharmaceutical Statistics
|
December 22, 2023
Data-driven monitoring for phase II clinical trial designs based on percentile event time test
Yeonhee Park, Zhanpeng Xu
Biometrics
|
April 7, 2020
Discussion on "Predictively consistent prior effective sample sizes," by Beat Neuenschwander, Sebastian Weber, Heinz Schmidli, and Anthony O'Hagan
Yeonhee Park, Ruitao Lin
Statistical Methods in Medical Research
|
July 17, 2025
Group sequential designs for survival outcomes with adaptive randomization
Yaxian Chen, Yeonhee Park
Page
of 8